TrialJournal of Parkinson's disease2024

A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.

Milton H Werner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.